Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Herbal Fen Phen Lawyers ( http://www.herbalfenphenlawyers.com/ ). Herbal Fen Phen products have been marketed to former patients as a “natural alternative” to Fen Phen, despite warnings from the FDA that h...

China Medical Technologies Announces Change of Independent Auditors

BEIJING, Aug. 7 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced the appointment of PricewaterhouseCoope...

Watson Announces Limited Recall Of Fentanyl Transdermal System

MORRISTOWN, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the United States is being voluntarily recalled from who...

Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures

NEW YORK, Aug. 7 /PRNewswire/ -- Duane Reade Holdings, Inc. announced today the expiration and the final results of the previously announced offers by its wholly-owned subsidiaries, Duane Reade Inc. and Duane Reade (collectively, the "Issuers"), to purchase for cash (i) any and all of th...

Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015

NEW YORK, Aug. 7 /PRNewswire/ -- Duane Reade Holdings, Inc. announced today that its wholly-owned subsidiaries, Duane Reade Inc. and Duane Reade (collectively, the "Issuers"), had closed their offering of $300.0 million aggregate principal amount of Senior Secured Notes due August 1, 2015 (th...

Surgical Care Affiliates Announces Investor Conference Call to Discuss 2009 Second Quarter Results

BIRMINGHAM, Ala., Aug. 7 /PRNewswire/ -- Surgical Care Affiliates ("SCA") today announced that it will host an investor conference call at 11:00 a.m. Eastern Time on Monday, August 17, 2009, to discuss its 2009 second quarter operating results. A 30-day replay will be available approxim...

Nuvo Announces 2009 second quarter financial results

MISSISSAUGA, ON, Aug. 7 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, today announced its ...

GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update

ATLANTA, Aug. 7 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, biopharmaceutical firm (the "Company"), developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its finan...

NATB Announces Partnership With Ronald McDonald House Charities(R)

OAK BROOK, Ill., Aug. 7 / PRNewswire / -- Today, Ronald McDonald House Charities ((R)) (RMHC ((R)) ) announced a multi-year partnership with the National Association of Ticket Brokers (NATB) that includes ticket donations to select Ronald McDonald House Charities in the United St...

LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense

WASHINGTON, Aug. 6 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) said today that bids are now being requested for another $11.8 million of the $20 million lung cancer research project funded through the Department of Defense's Congressionally Directed Medical Research Program (CD...

ThermoGenesis Announces Launch of Res-Q System; New Device Expands Company's Presence in Bone Marrow Sector

RANCHO CORDOVA, Calif., Aug. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products for processing and storing adult stem cells, announced today the introduction of the Res-Q(TM) 60 BMC ("Res-Q") System, an automated cell processing...

Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results

SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced unaudited financial results for the three months ended June 30, 2009. Three Months Ended June 30, 2...

AMN Healthcare Announces Second Quarter 2009 Results

SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- AMN Healthcare Services, Inc. (NYSE: AHS ) today announced operating results for the second quarter 2009, which were in line with management's expectations. Financial highlights for the three months ended June 30, 2009 include: ...

IRIDEX Announces Second Quarter 2009 Conference Call and Release Date

MOUNTAIN VIEW, Calif., Aug. 6 /PRNewswire-FirstCall/ -- IRIDEX Corporation (NASDAQ: IRIX ) today announced that it will release its second quarter 2009 financial results after the market closes on Thursday, August 13, 2009. In conjunction with the release, the Company will host a ...

NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions

PHOENIX, Aug. 6 /PRNewswire-FirstCall/ -- NutraCea (OTC: NTRZ) , a world leader in stabilized rice bran nutrient research and technology, today announced the Company has entered into a forbearance agreement with Wells Fargo Bank, N. A. ("Wells Fargo") relating to the previously disclosed...

ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program

EXTON, Pa., Aug. 6 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that dosing has begun in the Phase 1 clinical trial for NTCD (non-toxigenic Clostridium difficile ), a novel treatment approach for preventing recurrent Clostridium difficile infections (...

Feline Pine Announces National 'Take Your Cat to the Vet Day' August 22

WEST PALM BEACH, Fla., Aug. 6 /PRNewswire/ -- Cats seem so independent, it's easy for their owners to get caught up in work, family and every day life and forget to bring them into the veterinarian for regular annual exams. In a recent national survey conducted in Spring 2009 by F...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

MOUNTAIN VIEW, Calif., Aug. 6 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) announced today the pricing of its previously announced public offering of 3,500,000 shares of its common stock at a public offering price of $9.70 per share. Net proceeds, after esti...

Global Health Trax, Inc. Announces New Marketing Campaign for Oxygen Elements Max Product

VISTA, Calif., Aug. 6 /PRNewswire/ -- Nutritional supplement manufacturing and distribution company Global Health Trax, Inc. today launched a new marketing campaign touting its flagship, patented nutritional supplement product Oxygen Elements(R) Max as an ideal booster for popular e...

CBI Announces the Agenda for Their Upcoming Access Federal Stimulus Incentives for Electronic Health Records Conference

BOSTON, Aug. 6 /PRNewswire/ -- The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce their full agenda which includes Dr. Paul Tang, Vice President and Chief Medical Information Officer, Palo Alto Medical Foundation, as the keynote spe...

Smart Balance Announces 2009 Second Quarter Results

( ) PARAMUS, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Smart Balance, Inc. (Nasdaq: SMBL ) today announced its results for the second quarter ended June 30, 2009. The Company reported net sales of $58.2 million, an increase of 21.2% versus year ago, and earni...

Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer

HOUSTON, Aug. 6 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc. today announced dosing of the first patient in a Phase I/II clinical trial of BP-GMAX-CD1, a novel pharmacologically regulated dendritic cell vaccine for the treatment of prostate cancer. The disease-specific trial is be...

EANS-News: Alapis Announces its Share Capital Increase to Raise c. EUR 451.1 million

ATHENS, Greece, August 6 /PRNewswire/ -- - Not for Release, Publication or Distribution Directly or Indirectly in or Into the United States, Canada, Australia, South Africa or Japan or any Other Jurisdiction in Which Such Publication or Distribution Would be Unlawful ...

SXC Health solutions announces record second quarter financial results

2009 guidance revised higher based on solid year-to-date performance and positive outlook for the remainder of the year LISLE, IL, Aug. 6 /PRNewswire-FirstCall/ - SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI , TSX: SXC), announces its financial results for the...

DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call

WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (Nasdaq GM: DUSA ) announces that its corporate highlights and second quarter financial results press release will be issued on Tuesday, August 11 at 6:30 a.m. to be followed by a conference call at 8:30 ...

US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board

THE WOODLANDS, Texas, Aug. 5 /PRNewswire/ -- Today, the Board of Directors of US Oncology Holdings, Inc. and its wholly owned subsidiary, US Oncology, Inc. (collectively, "US Oncology" or the "Company"), announced that, effective Sept. 1, 2009, R. Dale Ross is retiring as Executive Chair...

ULURU Inc. Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 30, 2009 and to Provide a Business Update

Addison, TEXAS, Aug. 5 /PRNewswire-FirstCall/ -- U L URU Inc. (NYSE Alternext: ULU) today announced that it has scheduled a conference call to discuss the second quarter ended June 30, 2009 financial results and provide a general business update on Monday, August 17, 200...

XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution

MENLO PARK, Calif., Aug. 5 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced that it has provided written notice to The NASDAQ Stock Market, Inc. ("NASDAQ") of its intention to voluntarily delist its common stock from the NASDAQ Global Market. The Company currently ...

YMCA of the USA Announces 16 Communities Selected for Statewide Policy Change Initiative to Reverse the Childhood Obesity Epidemic

Communities in three states will serve as initial sites for initiative to promote healthier options in communities CHICAGO, Aug. 5 /PRNewswire-USNewswire/ -- Sixteen communities in Connecticut, Kentucky and Tennessee have been selected to build statewide networks to help reduce ...

MaxLife Fund Corp. announces cancellation of 14,050,000 Common Shares

NEW JERSEY, Aug. 5 /PRNewswire-FirstCall/ - MaxLife Fund Corp. (OTC:MXFD), have announced that some of its founding shareholders have agreed to cancel a total of 14,050,000 shares of the Company's common stock in order to increase overall shareholder value for the Company. Bennett Kurtz, Chief E...

Sagent Pharmaceuticals Announces Launch of First Two Oncolytic Products: Fludarabine Phosphate for Injection, USP and Epirubicin Hydrochloride Injection

SCHAUMBURG, Ill., Aug. 5 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched fludarabine phosphate for injection, USP and epirubicin hydrochloride injection. IMS data indicates the combined U.S. market...

Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma

RESEARCH TRIANGLE PARK, N.C., Aug. 5 /PRNewswire/ -- Addrenex Pharmaceuticals, a specialty pharmaceutical company dedicated to developing treatments to regulate the adrenergic system, announced today an exclusive partnership with Dream Pharma. In keeping with its long-range plan to ...

MultiVu Video Feed: SCIELE PHARMA ANNOUNCES AVAILABILITY OF ULESFIA(TM), FIRST AND ONLY FDA-APPROVED NON-NEUROTOXIC HEAD LICE TREATMENT

Sciele Pharma, Inc., a Shionogi Company, today announced the availability of Ulesfia (Benzyl Alcohol Lotion 5%), the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects. Approved by the U.S. Food & Drug Administration (FDA),...

TrinityCare Senior Living Announces Further Expansion in Houston Area

FRIENDSWOOD, Texas, Aug. 5 /PRNewswire-FirstCall/ -- TrinityCare Senior Living, Inc. (OTC Bulletin Board: TCSR), which develops, manages and owns faith-based senior living facilities, today announced the execution of a funding agreement with a national lender for the developmen...

DSM Announces SafeBridge(R) Potent Compound Safety Certification

PARSIPPANY, N.J., Aug. 5 /PRNewswire/ -- DSM Pharmaceutical Products has announced that their Greenville, North Carolina facility has received the( )Potent Compound Safety Certification from SafeBridge((R)) Consultants, Inc. headquartered in Mountain View, California. The Certification ...

Misonix Announces the Sale of Its Labcaire Business for up to $5.6 Million

FARMINGDALE, N.Y., Aug. 5 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON ), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced the sale of its...

ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride

EXTON, Pa., Aug. 4 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that the Pharmaceutical Science and Clinical Pharmacology Advisory Committee supports the FDA's Office of Generic Drugs (OGD) draft guidelines on bioequivalence (BE) f...

Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes

WALTHAM, Mass., Aug. 4 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it intends to offer $150 mill...

Crisco(R) Announces the Crisco Live Smart, Cook Smarter Contest Winners

ORRVILLE, Ohio, Aug. 4 /PRNewswire/ -- Today, the makers of Crisco (R) announced the winners of the Crisco Live Smart, Cook Smarter Contest. Inspired by the versatility and great taste of Crisco (R) Puritan (R) Canola Oil with Omega-3 DHA, one grand prize winner will recei...

CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine

Citizens Commission on Human Rights International Announces FDA Reported Psychiatric Drug Side Effects Search Engine: Decrypted FDA reports reveal 4,260 suicides, 2,452 additional deaths, 195 homicides from 2004-2006 alone Los Angeles, CA (PRWEB) -- For the first time t...